BACKGROUND: Experience of just under 5 years has shown that balloon kyphoplasty can be just as successfully employed as the longer-stablished vertebroplasty for the treatment of back pain due to recent or prior osteoporotic fractures as well as new traumatic fractures. MATERIAL AND METHOD: Among 345 patients with a total of 690 treated vertebral bodies, the change in pain symptomatology was analyzed for a follow-up period of 12 months in 40 study patients who underwent kyphoplasty and a control group of 20 patients. In addition, the pain experienced by a further 29 patients with new traumatic vertebral body fractures was monitored over a 12-month period. These fractures were partly managed by fixateur interne alone and by a combination of fixateur interne and kyphoplasty. RESULTS: The 40 patients treated by kyphoplasty had a baseline VAS score of 26.2+/-2.00, which increased to 44.4+/-3.11 after 12 months, while the respective scores for the control group were 33.6+/-4.21 and 34.3+/-4.35. In the 29 patients with new traumatic vertebral body fractures, the initial VAS score was 62 and after 12 months a distinct reduction of pain was noted with a score of 20 (100 = maximum pain, 0 = no pain). The number of times that the 40 patients managed by kyphoplasty had to consult their general practitioner was significantly reduced by the pain therapy. CONCLUSION: Balloon kyphoplasty verifiably improved the pain symptomatology after vertebral fracture over a period of 12 months. Comparison with the control group, which received the same osteoporosis drug therapy, confirmed the effect of this minimally invasive treatment form.
BACKGROUND: Experience of just under 5 years has shown that balloon kyphoplasty can be just as successfully employed as the longer-stablished vertebroplasty for the treatment of back pain due to recent or prior osteoporotic fractures as well as new traumatic fractures. MATERIAL AND METHOD: Among 345 patients with a total of 690 treated vertebral bodies, the change in pain symptomatology was analyzed for a follow-up period of 12 months in 40 study patients who underwent kyphoplasty and a control group of 20 patients. In addition, the pain experienced by a further 29 patients with new traumatic vertebral body fractures was monitored over a 12-month period. These fractures were partly managed by fixateur interne alone and by a combination of fixateur interne and kyphoplasty. RESULTS: The 40 patients treated by kyphoplasty had a baseline VAS score of 26.2+/-2.00, which increased to 44.4+/-3.11 after 12 months, while the respective scores for the control group were 33.6+/-4.21 and 34.3+/-4.35. In the 29 patients with new traumatic vertebral body fractures, the initial VAS score was 62 and after 12 months a distinct reduction of pain was noted with a score of 20 (100 = maximum pain, 0 = no pain). The number of times that the 40 patients managed by kyphoplasty had to consult their general practitioner was significantly reduced by the pain therapy. CONCLUSION:Balloon kyphoplasty verifiably improved the pain symptomatology after vertebral fracture over a period of 12 months. Comparison with the control group, which received the same osteoporosis drug therapy, confirmed the effect of this minimally invasive treatment form.
Authors: P Lips; C Cooper; D Agnusdei; F Caulin; P Egger; O Johnell; J A Kanis; S Kellingray; A Leplege; U A Liberman; E McCloskey; H Minne; J Reeve; J Y Reginster; M Scholz; C Todd; M C de Vernejoul; I Wiklund Journal: Osteoporos Int Date: 1999 Impact factor: 4.507
Authors: Christian Kasperk; Jochen Hillmeier; Gerd Nöldge; Ingo A Grafe; Katharina Dafonseca; Dorothea Raupp; Hubert Bardenheuer; Martin Libicher; Ute Monika Liegibel; Ulrike Sommer; Ulrike Hilscher; Walter Pyerin; Marcus Vetter; Hans-Peter Meinzer; Peter-Jürgen Meeder; Rod S Taylor; Peter Nawroth Journal: J Bone Miner Res Date: 2004-12-06 Impact factor: 6.741
Authors: Ingo A Grafe; Katharina Da Fonseca; Jochen Hillmeier; Peter-Jürgen Meeder; Martin Libicher; Gerd Nöldge; Hubert Bardenheuer; Walter Pyerin; Linus Basler; Christel Weiss; Rod S Taylor; Peter Nawroth; Christian Kasperk Journal: Osteoporos Int Date: 2005-08-03 Impact factor: 4.507
Authors: D K Roy; T W O'Neill; J D Finn; M Lunt; A J Silman; D Felsenberg; G Armbrecht; D Banzer; L I Benevolenskaya; A Bhalla; J Bruges Armas; J B Cannata; C Cooper; J Dequeker; M N Diaz; R Eastell; O B Yershova; B Felsch; W Gowin; S Havelka; K Hoszowski; A A Ismail; I Jajic; I Janott; O Johnell; J A Kanis; G Kragl; A Lopez Vaz; R Lorenc; G Lyritis; P Masaryk; C Matthis; T Miazgowski; C Gennari; H A P Pols; G Poor; H H Raspe; D M Reid; W Reisinger; C Scheidt-Nave; J J Stepan; C J Todd; K Weber; A D Woolf; J Reeve Journal: Osteoporos Int Date: 2003-01 Impact factor: 4.507
Authors: J Hillmeier; I Grafe; K Da Fonseca; P J Meeder; G Nöldge; M Libicher; H J Kock; M Haag; C Kasperk Journal: Orthopade Date: 2004-08 Impact factor: 1.087